title: Mechanisms of resistance in bacteria: an evolutionary approach.
abstract: Acquisition of resistance is one of the major causes of failure in therapy of bacterial infections. According to the World Health Organization (WHO), thousands of deaths caused by Salmonella sp., Escherichia coli, Staphylococcus aureus or Mycobacteria tuberculosis are due to failure in therapy caused by resistance to the chemotherapeutic agents. Understanding the mechanisms of resistance acquisition by the bacterial strains is therefore essential to prevent and overcome resistance. However, it is very difficult to extrapolate from in vitro studies, where the variables are far less and under constant control, as compared to what happens in vivo where the chosen chemotherapeutic, its effective dose, and the patient's immune system are variables that differ substantially case-by-case. The aim of this review is to provide a new perspective on the possible ways by which resistance is acquired by the bacterial strains within the patient, with a special emphasis on the adaptive response of the infecting bacteria to the administered antibiotic.
authors.affiliation: Unidade de Parasitologia e Microbiologia Médica, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Rua da Junqueira 100, 1349-008 Lisboa, Portugal ; Institute of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm Tér 10, 6720 Szeged, Hungary.
authors.forename: Ana
authors.initials: A
authors.lastname: Martins
authors.forename: Attila
authors.initials: A
authors.lastname: Hunyadi
authors.forename: Leonard
authors.initials: L
authors.lastname: Amaral
keywords: Multi-drug resistance; acquisition of resistance; efflux pumps.
references.citation: Biochim Biophys Acta. 2009 May;1794(5):834-43
references.pmid: 19230852
references.citation: Nat Rev Microbiol. 2006 Aug;4(8):629-36
references.pmid: 16845433
references.citation: Proc Natl Acad Sci U S A. 2009 May 12;106(19):8009-14
references.pmid: 19383799
references.citation: Recent Pat Antiinfect Drug Discov. 2011 May;6(2):110-7
references.pmid: 21517742
references.citation: Adv Enzymol Relat Areas Mol Biol. 2011;77:61-108
references.pmid: 21692367
references.citation: Microbiol Mol Biol Rev. 2003 Dec;67(4):593-656
references.pmid: 14665678
references.citation: Expert Opin Investig Drugs. 2011 Dec;20(12):1665-76
references.pmid: 22014039
references.citation: Curr Drug Targets. 2008 Sep;9(9):797-807
references.pmid: 18781925
references.citation: In Vivo. 2012 Mar-Apr;26(2):277-85
references.pmid: 22351670
references.citation: Curr Biol. 2009 Jun 9;19(11):R437-41
references.pmid: 19515346
references.citation: FEBS Lett. 2011 Jun 6;585(11):1682-90
references.pmid: 21549704
references.citation: BMC Microbiol. 2011 Feb 18;11:35
references.pmid: 21332993
references.citation: Adv Drug Deliv Rev. 2005 Jul 29;57(10):1486-513
references.pmid: 15939505
references.citation: Nat Rev Microbiol. 2008 Dec;6(12):893-903
references.pmid: 18997824
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4601-8
references.pmid: 18216259
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19484-9
references.pmid: 17148599
references.citation: Curr Drug Targets. 2008 Sep;9(9):779-88
references.pmid: 18781923
references.citation: Antimicrob Agents Chemother. 2004 Nov;48(11):4163-70
references.pmid: 15504836
references.citation: Adv Enzymol Relat Areas Mol Biol. 2011;77:1-60
references.pmid: 21692366
references.citation: PLoS One. 2007 Apr 11;2(4):e365
references.pmid: 17426813
references.citation: J Bacteriol. 2011 May;193(9):2252-60
references.pmid: 21398557
references.citation: Nature. 1992 Aug 27;358(6389):727-33
references.pmid: 1380671
references.citation: PLoS One. 2008 Jul 23;3(7):e2765
references.pmid: 18648511
references.citation: Trends Microbiol. 2011 Sep;19(9):456-63
references.pmid: 21816616
references.citation: Fitoterapia. 2011 Jan;82(1):17-33
references.pmid: 21108995
references.citation: J Ethnopharmacol. 2011 May 17;135(2):590-3
references.pmid: 21420479
references.citation: In Vivo. 2010 Jul-Aug;24(4):409-24
references.pmid: 20668307
references.citation: J Antimicrob Chemother. 2012 Feb;67(2):473-7
references.pmid: 22134348
references.citation: Chem Biol. 2005 May;12(5):507-9
references.pmid: 15911368
references.citation: Curr Opin Microbiol. 2009 Oct;12(5):520-7
references.pmid: 19695947
references.citation: Drugs. 2009 Aug 20;69(12):1555-623
references.pmid: 19678712
references.citation: IUBMB Life. 2008 Sep;60(9):569-74
references.pmid: 18481812
references.citation: Nat Biotechnol. 2009 May;27(5):462-4
references.pmid: 19396160
references.citation: FEMS Microbiol Rev. 2009 Jan;33(1):44-65
references.pmid: 19054120
references.citation: J Antimicrob Chemother. 2011 Jun;66(6):1311-7
references.pmid: 21415038
references.citation: Curr Drug Targets. 2008 Sep;9(9):750-9
references.pmid: 18781921
references.citation: Biochim Biophys Acta. 2009 May;1794(5):808-16
references.pmid: 19100346
references.citation: Fam Pract. 1984 Dec;1(4):219-21
references.pmid: 6530085
references.citation: Br J Pharmacol. 2012 Feb;165(4):845-57
references.pmid: 21864314
references.citation: Int J Antimicrob Agents. 2010 Aug;36(2):164-8
references.pmid: 20494558
references.citation: Chem Commun (Camb). 2011 Jul 21;47(27):7559-66
references.pmid: 21594283
references.citation: Antimicrob Agents Chemother. 2007 Sep;51(9):3190-8
references.pmid: 17606680
references.citation: In Vivo. 2012 Mar-Apr;26(2):231-6
references.pmid: 22351663
references.citation: Curr Drug Targets. 2008 Sep;9(9):789-96
references.pmid: 18781924
references.citation: Antimicrob Agents Chemother. 2005 Aug;49(8):3578-82
references.pmid: 16048990
references.citation: Chem Rev. 2011 Sep 14;111(9):5492-505
references.pmid: 21786783
references.citation: Annu Rev Microbiol. 2001;55:357-80
references.pmid: 11544360
references.citation: Ann Med. 2007;39(3):162-76
references.pmid: 17457715
references.citation: J Ethnopharmacol. 2011 Apr 12;134(3):851-64
references.pmid: 21291981
references.citation: Indian J Med Res. 2011 May;133:535-40
references.pmid: 21623040
references.citation: Adv Enzymol Relat Areas Mol Biol. 2011;77:167-235
references.pmid: 21692370
references.citation: Microbiology (Reading). 2008 Jul;154(Pt 7):1845-1858
references.pmid: 18599814
references.citation: Biochim Biophys Acta. 2006 Aug;1757(8):913-30
references.pmid: 16624250
references.citation: Yakugaku Zasshi. 2012;132(1):45-50
references.pmid: 22214579
references.citation: Curr Drug Discov Technol. 2010 Mar;7(1):2-12
references.pmid: 20156139
references.citation: Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011
references.pmid: 18947320
references.citation: Philos Trans R Soc Lond B Biol Sci. 2007 Jul 29;362(1483):1195-200
references.pmid: 17360275
references.citation: Indian J Med Res. 2011 Sep;134:281-94
references.pmid: 21985810
references.citation: J Antibiot (Tokyo). 2011 Jan;64(1):73-8
references.pmid: 21102598
references.citation: Biochemistry. 2010 Aug 17;49(32):6928-35
references.pmid: 20604536
references.citation: Antimicrob Agents Chemother. 2002 Sep;46(9):2804-10
references.pmid: 12183232
references.citation: FEMS Microbiol Rev. 2012 Mar;36(2):340-63
references.pmid: 21707670
references.citation: Mayo Clin Proc. 2012 Feb;87(2):198-208
references.pmid: 22305032
references.citation: Drug Resist Updat. 2003 Jun;6(3):137-45
references.pmid: 12860461
references.citation: Int J Antimicrob Agents. 2009 Dec;34(6):602-4
references.pmid: 19734019
references.citation: J Antimicrob Chemother. 2010 Apr;65(4):799-801
references.pmid: 20147322
references.citation: BMC Infect Dis. 2010 Jun 02;10:148
references.pmid: 20525206
references.citation: Antimicrob Agents Chemother. 2009 Mar;53(3):1080-7
references.pmid: 19104017
references.citation: Curr Opin Infect Dis. 1999 Dec;12(6):529-36
references.pmid: 17035817
references.citation: J Bacteriol. 2004 Oct;186(20):6689-97
references.pmid: 15466019
references.citation: Trends Microbiol. 2008 Jun;16(6):284-90
references.pmid: 18467098